Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse


Journal article


Guillermo Lorenzo, Nadia di Muzio, Chiara Lucrezia Deantoni, Cesare Cozzarini, Andrei Fodor, Alberto Briganti, Francesco Montorsi, Víctor M. Pérez-García, Hector Gomez, Alessandro Reali
iScience, vol. 25(11), 2022, p. 105430


Cite

Cite

APA
Lorenzo, G., di Muzio, N., Deantoni, C. L., Cozzarini, C., Fodor, A., Briganti, A., … Reali, A. (2022). Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse. IScience, 25(11), 105430.

Chicago/Turabian
Lorenzo, Guillermo, Nadia di Muzio, Chiara Lucrezia Deantoni, Cesare Cozzarini, Andrei Fodor, Alberto Briganti, Francesco Montorsi, Víctor M. Pérez-García, Hector Gomez, and Alessandro Reali. “Patient-Specific Forecasting of Postradiotherapy Prostate-Specific Antigen Kinetics Enables Early Prediction of Biochemical Relapse.” iScience 25, no. 11 (2022): 105430.

MLA
Lorenzo, Guillermo, et al. “Patient-Specific Forecasting of Postradiotherapy Prostate-Specific Antigen Kinetics Enables Early Prediction of Biochemical Relapse.” IScience, vol. 25, no. 11, 2022, p. 105430.


Share